Correspondence Re: "C. Guo, K.E. McMartin, The cytotoxicity of oxalate, metabolite of ethylene glycol, is due to calcium oxalate monohydrate formation, Toxicology 208 (3) (2005) 347-355"

Toxicology

Volumn 222, Issue 1-2, 2006, Pages 160-161

  Lewin Smith, Michael R ^a   Kalasinsky, Victor F ^a   Mullick, Florabel G ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; ETHYLENE GLYCOL; OXALIC ACID; WHEWELLITE; OXALIC ACID DERIVATIVE; WEDDELLITE;

CALCIUM OXALATE STONE; CALCIUM URINE LEVEL; CHEMICAL ANALYSIS; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HYDRATION; INTOXICATION; IONIC STRENGTH; LETTER; MOLECULAR STABILITY; PH MEASUREMENT; PRIORITY JOURNAL; THERMODYNAMICS; UROLITHIASIS; ANIMAL; CHEMISTRY; CRYSTALLIZATION; METABOLISM; NOTE; URINE;

ANIMALS; CALCIUM OXALATE; CRYSTALLIZATION; ETHYLENE GLYCOL; HUMANS; OXALATES; OXALIC ACID;

EID: 33744986526     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.02.005     Document Type: Letter

References (15)

1. Chaplin A.J. Histopathological occurrence and characterization of calcium oxalate: a review. J. Clin. Pathol. 30 (1977) 800-811
2. Friedman E.A., Greenberg J.B., Merrill J.P., and Dammin G.J. Consequences of ethylene glycol poisoning. Am. J. Med. 32 (1962) 891-902
3. Guo C., and McMartin K.E. The cytotoxicity of oxalate, metabolite of ethylene glycol, is due to calcium oxalate monohydrate formation. Toxicology 208 (2005) 347-355
4. Huhn K.M., and Rosenberg F.M. Critical clue to ethylene glycol poisoning. Can. Med. Assoc. J. 152 (1995) 193-195
5. Jacobsen D., Akesson I., and Shefter E. Urinary calcium oxalate monohydrate crystals in ethylene glycol poisoning. Scand. J. Clin. Lab. Invest. 42 (1982) 231-234
6. Johnson F.B. A method for demonstrating calcium oxalate in tissue sections. J. Histochem. Cytochem. 4 (1956) 404-405
7. Johnson F.B., and Pani K. Histochemical identification of calcium oxalate. Arch. Pathol. 74 (1962) 347-351
8. Katoh R., Suzuki K., Hemmi A., and Kawaoi A. Nature and significance of calcium oxalate crystals in normal human thyroid gland. A clinicopathological and immunohistochemical study. Virchows Arch. A Pathol. Anat. 422 (1993) 301-306
9. Lewis R.D., Lowenstam H.A., and Rossman G.R. Oxalate nephrosis and crystalline myocarditis. Arch. Pathol. 98 (1974) 149-155
10. Mandel N.S., and Mandel G.S. Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition. J. Urol. 142 (1989) 1516-1521
11. Reid J.D., Choi C.-H., and Oldroyd N.O. Calcium oxalate crystals in the thyroid. Their identification, prevalence, origin, and possible significance. Am. J. Clin. Pathol. 87 (1987) 443-454
12. Reid J.D. Calcium oxalate in mammalian thyroids: a re-evaluation. J. Comp. Pathol. 105 (1991) 109-115
13. Sheng X., Ward M.D., and Wesson J.A. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation. J. Am. Soc. Nephrol. 16 (2005) 1904-1908
14. Terlinsky A.S., Grochowski J., Geoly K.L., Stauch B.S., and Hefter L. Identification of atypical calcium oxalate crystalluria following ethylene glycol ingestion. Am. J. Clin. Pathol. 76 (1981) 223-226
15. Wesson J.A., Johnson R.J., Mazzali M., Beshensky A.M., Stietz S., Giachelli C., et al. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J. Am. Soc. Nephrol. 14 (2003) 139-147